Characterization and quantification of adeno-associated virus capsid-loading states by multi-wavelength analytical ultracentrifugation with UltraScan

Author:

Henrickson Amy1ORCID,Ding Xiaozhe2ORCID,Seal Austin G3,Qu Zhe2,Tomlinson Lauren4,Forsey John4ORCID,Gradinaru Viviana2ORCID,Oka Kazuhiro35ORCID,Demeler Borries16ORCID

Affiliation:

1. Department of Chemistry & Biochemistry, University of Lethbridge, Lethbridge, AB, T1K 3M4, Canada

2. Division of Biology & Biological Engineering, California Institute of Technology, Pasadena, CA 91125, USA

3. Gene Vector Core, Advanced Technology Cores, Baylor College of Medicine Houston, TX 77030, USA

4. Pharmaron Biologics Ltd, Speke, Liverpool, L24 8RB, UK

5. Department of Molecular & Cellular Biology, Baylor College of Medicine, TX 77030, USA

6. Department of Chemistry & Biochemistry, University of Montana, Missoula, MT 59812, USA

Abstract

Aim: We present multi-wavelength (MW) analytical ultracentrifugation (AUC) methods offering superior accuracy for adeno-associated virus characterization and quantification. Methods: Experimental design guidelines are presented for MW sedimentation velocity and analytical buoyant density equilibrium AUC. Results: Our results were compared with dual-wavelength AUC, transmission electron microscopy and mass photometry. In contrast to dual-wavelength AUC, MW-AUC correctly quantifies adeno-associated virus capsid ratios and identifies contaminants. In contrast to transmission electron microscopy, partially filled capsids can also be detected and quantified. In contrast to mass photometry, first-principle results are obtained. Conclusion: Our study demonstrates the improved information provided by MW-AUC, highlighting the utility of several recently integrated UltraScan programs, and reinforces AUC as the gold-standard analysis for viral vectors.

Funder

Beckman Institute CLOVER Center at Caltech and the NIH BRAIN Initiative Armamentarium

Canada Foundation for Innovation

NSF/XSEDE

NIH-NIGMS

Canada 150 Research Chairs program

Canadian Natural Science and Engineering Research Council

University of Texas

Cancer Prevention and Research Institute of Texas

Publisher

Future Medicine Ltd

Subject

Development,General Materials Science,Biomedical Engineering,Medicine (miscellaneous),Bioengineering

Reference50 articles.

1. The approved gene therapy drugs worldwide: from 1998 to 2019

2. US Food and Drug Administration. Approved cellular and gene therapy products. www.fda.gov/vaccines-blood-biologics/cellular-gene-therapy-products/approved-cellular-and-gene-therapy-products

3. ClinicalTrials.gov. Gene therapy clinical trials. https://clinicaltrials.gov/ct2/results?cond=&term=gene+therapy&cntry=&state=&city=&dist=

4. Adeno-associated virus vector as a platform for gene therapy delivery

5. Engineering adeno-associated virus vectors for gene therapy

Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3